WO2018016440A1 - Agent d'introduction, kit, procédé d'introduction de substance et procédé de criblage - Google Patents

Agent d'introduction, kit, procédé d'introduction de substance et procédé de criblage Download PDF

Info

Publication number
WO2018016440A1
WO2018016440A1 PCT/JP2017/025749 JP2017025749W WO2018016440A1 WO 2018016440 A1 WO2018016440 A1 WO 2018016440A1 JP 2017025749 W JP2017025749 W JP 2017025749W WO 2018016440 A1 WO2018016440 A1 WO 2018016440A1
Authority
WO
WIPO (PCT)
Prior art keywords
substance
cell
introduction
cells
membrane
Prior art date
Application number
PCT/JP2017/025749
Other languages
English (en)
Japanese (ja)
Inventor
昌之 村田
ふみ 加納
真隆 村上
Original Assignee
国立大学法人東京大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 国立大学法人東京大学 filed Critical 国立大学法人東京大学
Priority to JP2018528525A priority Critical patent/JP7093557B2/ja
Publication of WO2018016440A1 publication Critical patent/WO2018016440A1/fr

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology

Definitions

  • the present invention relates to an introduction agent, a kit, a substance introduction method, and a screening method.
  • This application claims priority based on Japanese Patent Application No. 2016-141219 for which it applied to Japan on July 19, 2016, and uses the content here.
  • CPC Cell-penetrating-peptide
  • the present inventors have developed a reversible membrane perforation method using streptococcal toxin streptolysin O (SLO).
  • SLO streptococcal toxin streptolysin O
  • semi-intact cells in which the plasma membrane is partially permeable can be obtained.
  • semi-intact cells are prepared from other cells and organs by draining the original cytoplasm while maintaining the structure and function of organelles and cytoskeleton and their relative spatial arrangement almost intact. Can be “exchanged” for the cytoplasm.
  • a pathological environment can be constructed in a cell by exchanging the cytoplasm of a semi-intact cell with the cytoplasm obtained from the pathological cell.
  • cytoplasm can be added from the outside at the time of re-encapsulation of the cell membrane to promote resealing of the cell membrane and damage recovery can be promoted, but it is a problem that adjustment of the cytoplasm is a troublesome work.
  • the present invention has been made in view of the above circumstances, and can introduce an introduction agent, a kit, a substance introduction method, and a method that can reduce damage to cells and enable high-efficiency introduction of substances into cells. Screening methods are provided.
  • the introduction agent according to the first aspect of the present invention contains a cholesterol-dependent cytolytic toxin whose optimum pH for membrane perforation activity at 30 ° C. or higher and 40 ° C. or lower is in the range of 0 to less than 6, and is a substance to cells Used for introduction.
  • the cholesterol-dependent cytolytic toxin may be listeriolysin O.
  • the introduction rate of the substance having a molecular weight of 1 kDa to 15 kDa may be higher than the introduction rate of the substance having a molecular weight of 30 kDa to 200 kDa.
  • the pH of the introducing agent may be 6 or more and 10 or less.
  • the cholesterol-dependent cytolytic toxin content may be 0.01 ⁇ g / mL or more and 1 ⁇ g / mL or less.
  • the kit according to the second aspect of the present invention includes the introduction agent according to the first aspect and is used for introducing a substance into a cell.
  • the substance introduction method is a method including the step 1 of bringing the introduction agent according to the first aspect into contact with a cell to perforate a cell membrane and introducing the substance into the cell. Furthermore, after the step 1, a step 2 may be included in which a solution containing calcium ions is brought into contact with the cells in which the pores are formed, and the pores are re-encapsulated. In the step 2, the pores may be re-encapsulated without contacting a liquid containing foreign cytoplasm with the cells in which the pores are formed. In the step 1, the perforation may be performed by allowing the cholesterol-dependent cytolytic toxin to act on the cells under conditions of pH 6 or more and 10 or less. The molecular weight of the substance to be introduced may be 0.1 kDa or more and 20 kDa or less. The substance to be introduced may contain a nucleic acid.
  • the method for screening a substance according to the fourth aspect of the present invention is a method using the substance introduction method according to the third aspect, wherein the substance to be introduced into the cell is a test substance, and the introduction agent is brought into contact with the cell.
  • a step A in which a cell membrane is perforated and a test substance is introduced into the cell.
  • the cell into which the test substance is introduced or a preparation thereof is compared with a cell into which the test substance is not introduced or a preparation thereof. You may include the process B which evaluates the said to-be-tested substance.
  • the introduction agent, the kit, and the introduction method according to the above aspect damage to cells is difficult to occur, and a substance can be introduced into cells with high efficiency.
  • the screening method according to the above aspect since it is difficult to cause damage to cells and a test substance can be introduced into cells with high efficiency, screening of a test substance with high accuracy reflecting the original function of the cell is possible. It becomes.
  • FIG. 10 It is a schematic diagram explaining the substance introduction method of this embodiment. It is a figure which shows the measurement result of the fluorescein fluorescence (10 kDa) of the cell acquired in Example 1.
  • FIG. 10 It is a figure which shows the measurement result of the fluorescein fluorescence (40 kDa) of the cell acquired in Example 1.
  • FIG. It is a figure which shows the measurement result of the fluorescein fluorescence (70 kDa) of the cell acquired in Example 1.
  • FIG. It is a figure which shows the measurement result of the FITC fluorescence (150 kDa) of the cell acquired in Example 1.
  • Example 3 It is an image which shows the comparison result of the cell form of the reseal cell perforated by LLO and the reseal cell perforated by SLO acquired in Example 2.
  • Example 3 it is an image which shows the result of having detected the protein phosphorylated by PKA by Western blotting.
  • Example 3 it is an image which shows the result of having introduced the cell impermeable cAMP analog into the cell by the substance introduction method according to the present embodiment and confirming the function of the cAMP analog in the cell.
  • Example 4 it is an image which shows the result of having detected the protein phosphorylated by PKA by Western blotting.
  • FIG. 9B is a graph in which the brightness of “band-e”, which is a protein phosphorylated by PKA, with respect to the brightness of GAPDH is quantified from the detection result by Western blotting in FIG. 9A in Example 4.
  • FIG. 4 a membrane-impermeable cAMP analog or a membrane-permeable PKA activator (db-cAMP) is introduced into a cell by the substance introduction method according to this embodiment, and the cAMP analog or db-cAMP in the cell is introduced. It is an image which shows the result of having confirmed the function of this by Western blotting.
  • db-cAMP membrane-impermeable cAMP analog or a membrane-permeable PKA activator
  • Example 4 it is the graph which quantified the brightness
  • Example 4 it is an image which shows the result of having introduced the membrane impermeable cAMP analog into the cell by the substance introduction method according to this embodiment and confirming the function of the cAMP analog in the cell by Western blotting.
  • FIG. 10 is a schematic diagram of each step in Example 5.
  • Example 5 it is an image which shows the result of having introduced the membrane-impermeable AKT inhibitor into the cell by the substance introduction method according to the present embodiment and confirming the function of the AKT inhibitor in the cell by Western blotting.
  • Example 5 it is the graph which quantified the brightness
  • the introduction agent according to one embodiment of the present invention is used for substance introduction into cells, and the optimum pH of membrane perforation activity at 30 ° C. or more and 40 ° C. or less is in the range of 0 or more and less than 6. Contains cholesterol-dependent cytolytic toxin.
  • the introduction agent of the present embodiment will be described.
  • introducing a substance into a cell refers to introducing a substance into the inside of the cell membrane of a cell to which the substance is to be introduced.
  • the newly introduced substance may be the same kind of substance as the substance possessed by the cell into which the substance is to be introduced.
  • a nucleic acid having the same sequence as the nucleic acid of a cell that is a target of substance introduction is also included in the substance introduction into the cell.
  • the introduction agent of this embodiment is suitably used for the substance introduction method described later.
  • Examples of the substance to be introduced include those exemplified in the substance introduction method described later.
  • cholesterol-dependent cytolytic toxin refers to a substance that has membrane perforation activity that binds to cholesterol and forms pores in the cell membrane (perforates the cell membrane).
  • a toxin produced by streptococci is known as a cholesterol-dependent cytolytic toxin.
  • the toxin is a protein that binds to cholesterol on the cell membrane and then self-assembles on the cell membrane to form pores in the cell membrane.
  • the substance introduction means substance introduction through the pores formed in the cell membrane by cholesterol-dependent cytolytic toxin.
  • the substance can be introduced into cells with high efficiency and low damage.
  • a cell When a cell is to be treated while maintaining a good state of the cell, it is usually treated with a solution having a pH near neutral.
  • a cholesterol-dependent cytolytic toxin having an optimum pH in the range of 0 or more and less than 6 is used, the cell state is good and the membrane perforation activity is gently exerted. Is considered to be perforated.
  • the membrane perforation activity is at 30 ° C. or more and 40 ° C. or less, may be 33 ° C. or more and 38 ° C. or less, and may be 35 ° C. or more and 37 ° C. or less.
  • the optimum pH may be from pH 1 to less than 6, may be from pH 3 to 5.5, and may be from pH 4.5 to less than 5.5.
  • the optimum pH of the membrane perforation activity can be measured by a known method. For example, cholesterol-dependent cytolytic toxin is brought into contact with erythrocytes cultured at the above temperature and pH conditions. Next, the membrane perforation activity can be measured based on the degree of hemolytic activity (HU) of the blood cells from which the erythrocyte membrane is destroyed and hemoglobin is eluted. Furthermore, the pH at which membrane perforation activity is maximized can be determined as the optimum pH.
  • HU degree of hemolytic activity
  • the cholesterol-dependent cytolytic toxin in which the optimum pH for membrane perforation activity at 30 ° C. or more and 40 ° C. or less is in the range of 0 to less than 6, may be Listeriolysin O (LLO).
  • the introduction agent according to one embodiment of the present invention contains listeriolysin O (LLO) and is used for substance introduction into cells.
  • Listeriolysin O is a L. genus belonging to the genus Listeria. It is known to be produced by monocytogenes. LLO is L. It may be a monocytogenes LLO.
  • the toxin contained in the introduction agent of the present embodiment may be a protein having a function substantially equivalent to that of LLO.
  • LLO may be a naturally occurring protein of nature.
  • LLO may be a mutant or artificially modified protein having an amino acid sequence, modification, addition, or the like different from that of the natural type as long as it has a function equivalent to that of the natural type.
  • the reason why the LLO perforation causes less damage to the cells than the SLO perforation is probably because the diameter of the hole formed by the LLO is smaller than the diameter of the hole formed by the SLO.
  • it is considered that the outflow of cytoplasmic components is suppressed as compared with the reversible membrane perforation method using SLO, the cell is hardly damaged, and the cell state is improved.
  • the cell state is good, a good cell state can be realized without adding cytoplasm from the outside when the cell membrane is re-encapsulated (resealed).
  • the introduction rate of the substance introduced by the introduction agent of this embodiment is preferably such that the introduction rate of the substance having a molecular weight of 1 kDa to 15 kDa is higher than the introduction rate of a substance having a molecular weight of 30 kDa to 200 kDa, and a molecular weight of 7 kDa to 13 kDa. It is more preferable that the introduction rate of the substance is higher than the introduction rate of the substance having a molecular weight of 35 kDa to 55 kDa.
  • the introduction rate of the substance can be confirmed, for example, by the method described in the examples.
  • the present inventors measured the introduction rate of fluorescently labeled dextran having different molecular weights into cells, each having a molecular weight of 10 kDa, 40 kDa, 70 kDa, and 150 kDa, using LLO.
  • LLO In perforation by LLO, it was found that the introduction rate of dextran having a medium molecular weight (10 kDa) into cells was larger than that of dextran having other molecular weights (40 kDa, 70 kDa, 150 kDa).
  • SLO selective permeability of medium molecules has not been confirmed by reversible membrane perforation using SLO.
  • LLO it is considered that a pore having a diameter that can easily pass a substance having a molecular weight of 1 kDa to 15 kDa and that is difficult to pass a substance having a molecular weight of 30 kDa to 200 kDa can be formed. Therefore, it is considered that the substance that correlates with the molecular weight and can pass through the pores is sieved.
  • the fact that a substance can be introduced into a cell through a hole opened in the cell membrane can similarly cause components in the cell to flow out of the cell through the hole.
  • the molecular weight of enzymes contained in the cytoplasm is often about 20 kDa or less.
  • the introduction rate of substances with a molecular weight of 1 kDa or more and 15 kDa or less is higher than the introduction ratio of substances with a molecular weight of 30 kDa or more and 200 kDa or less, so that it is difficult to cause damage to cells. Can be introduced.
  • the introduction agent of this embodiment should just contain a cholesterol dependent cytolytic toxin.
  • the introduction agent of this embodiment may consist essentially of a cholesterol-dependent cytolytic toxin, or may contain an optional component other than the toxin.
  • substantially composed only of a cholesterol-dependent cytolytic toxin means that the introduction agent of the present embodiment comprises only a cholesterol-dependent cytolytic toxin, or detects any component other than the toxin. It means that only trace amount below the limit is included.
  • the content of cholesterol-dependent cytolytic toxin contained in 100% by mass of the introduction agent may be, for example, from 1% by mass to 100% by mass, or from 10% by mass to 98% by mass, 50 mass% or more and 90 mass% or less may be sufficient, and 60 mass% or more and 80 mass% or less may be sufficient.
  • the size of the substance that can pass through the pores varies depending on the concentration of cholesterol-dependent cytolytic toxin that acts on the cells. Therefore, the concentration of cholesterol-dependent cytolytic toxin that acts on cells may be adjusted according to the molecular weight of the substance to be introduced.
  • the form of the introduction agent is not particularly limited, and may be various forms such as a solid (powder, granule, etc.) and a liquid.
  • the powder include a dried product of cholesterol-dependent cytolytic toxin.
  • the moisture content of the powder may be 0% by mass or more and 20% by mass or less, and may be 5% by mass or more and 10% by mass or less.
  • the granular material include a compact of the powder.
  • the liquid include a dispersion or solution of cholesterol-dependent cytolytic toxin in which cholesterol-dependent cytolytic toxin is dispersed or dissolved in a medium.
  • the medium include aqueous solvents, and specific examples include various media used for cell culture such as water, buffer, and serum-free medium.
  • the introduction agent of this embodiment is preferably used for cultured cells, and may be added to a medium for culturing cultured cells.
  • the introduction agent of this embodiment may be provided and used as a medium in which cultured cells can be cultured.
  • culture refers to breeding or growing cells outside a living body (individual). The period of breeding or growth may be, for example, from 1 minute to 7 days, from 5 minutes to 16 hours, or from 10 minutes to 1 hour.
  • “medium” is a concept that generally refers to a cell culture medium.
  • the remaining components obtained by removing the cholesterol-dependent cytolytic toxin from the introduction agent are not limited to the medium, as long as the cells can be cultured even for a very short period of time. It may be a buffer or water.
  • components that can be contained in the medium include components contained in ordinary cell culture media. Specific examples of the component include nutritional components such as glucose, sodium chloride, vitamins and minerals, amino acids, growth factors, cell growth factors, differentiation-inducing factors, antibacterial agents, and antifungal agents. .
  • the content of cholesterol-dependent cytolytic toxin contained in the introduction agent is 0.01 ⁇ g / mL or more and 1 ⁇ g / mL or less per mL of the introduction agent. It is preferably 0.025 ⁇ g / mL or more and 0.6 ⁇ g / mL or less, more preferably 0.03 ⁇ g / mL or more and 0.5 ⁇ g / mL or less, and 0.05 ⁇ g / mL or more and 0.0. It is particularly preferably 3 ⁇ g / mL or less.
  • the introduction agent containing the cholesterol-dependent cytolytic toxin in the above-mentioned concentration range can cause less damage to the cells and make the substance introduction effect into the cells more uniform.
  • the introduction efficiency of a substance of medium molecule is high due to the influence of the diameter of pores formed in the cell membrane, but larger molecules can be introduced depending on the concentration.
  • the introduction rate of the substance having a molecular weight of 1 kDa or more and 15 kDa or less is higher than the introduction rate of the substance having a molecular weight of 30 kDa or more and 200 kDa or less
  • cholesterol contained in the introduction agent in the above concentration range The content of the dependent cytolytic toxin can be in the range of 0.05 ⁇ g / mL to 0.3 ⁇ g / mL.
  • the pH of the introduction agent may be pH 6 or more, 10 or less, 6.5 or more, 8 or less, or 7.0 or more, 7 .5 or less.
  • the pH is a measured value in a temperature range of 30 ° C. or higher and 40 ° C. or lower. With the introduction agent within the above range, the cells can be cultured better. Furthermore, it is preferable from the viewpoint that the membrane perforation activity of cholesterol-dependent cytolytic toxin having an optimum pH in the range of 0 to less than 6 is exhibited more gently.
  • LLO is considered to have an optimum pH in the range of 0 to less than 6, and has not been tried to be used for substance introduction.
  • the present inventors have surprisingly found that by using LLO, it is difficult to cause damage to cells, and substances can be introduced into cells with high efficiency.
  • the introduction agent of the present embodiment since it contains a cholesterol-dependent cytolytic toxin having an optimum pH in the range of 0 or more and less than 6, it is difficult to cause damage to the cell, and the substance is highly efficient in the cell. Can be introduced inside.
  • the kit which concerns on one Embodiment of this invention is equipped with the above-mentioned introduction agent, and is used for the substance introduction
  • the kit of this embodiment will be described based on the embodiment.
  • the kit of this embodiment may further include reagents such as a medium and a buffer, and reagents that promote reseal of the cell membrane such as calcium salt, ATP, and ATP regeneration system. .
  • the kit of this embodiment can be suitably used for the substance introduction method of this embodiment described later.
  • the kit of this embodiment can be provided with instructions describing the substance introduction method of this embodiment. In this way, by introducing reagents that can be used in the substance introduction method of the present embodiment, which will be described later, into a kit, the substance introduction method can be performed more easily and in a short time.
  • a substance introduction method is a method including the step 1 of bringing a substance into contact with a cell by bringing the aforementioned introduction agent into contact with the cell to perforate a cell membrane.
  • the introduction agent contains the cholesterol-dependent cytolytic toxin. That is, the substance introduction method of this embodiment may be a method including the step 1a of bringing the cholesterol-dependent cytolytic toxin into contact with a cell, perforating the cell membrane of the cell, and introducing the substance into the cell. .
  • the introduction agent that may be used in the substance introduction method may be a liquid containing cholesterol-dependent cytolytic toxin. Alternatively, it may be a medium containing cholesterol-dependent cytolytic toxin. Alternatively, it may be a liquid medium containing cholesterol-dependent cytolytic toxin.
  • the substance introduction method of the present embodiment will be described by taking as an example the case where the introduction agent is a liquid medium containing a cholesterol-dependent cytolytic toxin. By culturing the cells in the medium (introducing agent), the introducing agent is brought into contact with the cells.
  • the substance introduction method of the present embodiment will be described based on the embodiment with reference to FIG.
  • the substance introduction method of this embodiment is A perforating step of perforating a cell membrane by contacting the introduction agent with cells; An introducing step of introducing a substance into the cells through the holes formed in the cell membrane in the perforating step; After the introduction step, a re-encapsulation step of bringing a solution containing calcium ions into contact with the cells in which the pores are formed and re-encapsulating (resealing) the pores.
  • the perforation step is a step of perforating the cell membrane by bringing the introduction agent into contact with the cells.
  • (A) to (c) of FIG. 1 are schematic diagrams for explaining a perforation process.
  • the well W contains a medium M1 (introducing agent) containing cholesterol-dependent cytolytic toxin 1 (hereinafter sometimes referred to as “toxin 1”) and cells C. Contained.
  • toxin 1 cholesterol-dependent cytolytic toxin 1
  • examples of the cholesterol-dependent cytolytic toxin include those exemplified for the introduction agent.
  • toxin 1 when cell C is cultured in medium M1 (introducing agent) containing toxin 1, toxin 1 binds to cholesterol in the cell membrane of cell C, thereby binding to the cell membrane of cell C. To do.
  • the medium M1 containing the toxin 1 can be obtained, for example, by adding the toxin 1 to a known medium used for cell culture.
  • the medium component obtained by removing toxin 1 from medium M1 is not particularly limited, and a medium used for cell culture may be used, and a conventionally known medium may be used.
  • Specific examples of the known medium include, for example, DMEM (Dulbecco's Modified Eagle Medium), MEM (Minimum Essential Media), GMEM (Glasgow's MEM), and D-PBS (Dulbecco's Phosphate-Suffefer-Suffe medium Etc.
  • the concentration of toxin 1 contained in medium M1 (introducing agent) to be brought into contact with cells is preferably 0.01 ⁇ g / mL or more and 1 ⁇ g / mL or less, and 0.025 ⁇ g / mL or more and 0.6 ⁇ g / mL or less. Is more preferably 0.05 ⁇ g / mL or more and 0.3 ⁇ g / mL or less, and particularly preferably 0.08 ⁇ g / mL or more and 0.1 ⁇ g / mL or less.
  • the medium M1 containing the toxin 1 in the above-described concentration range has less damage to the cells and can make the substance introduction effect into the cells more uniform.
  • the amount ratio of the toxin 1 contained in the medium M1 and the cell C can be appropriately determined according to the cell type of the cell. For example, it is considered that the higher the cholesterol content in the cell membrane of the cell, the less the amount of toxin required for membrane perforation. When the cholesterol content in the cell membrane is high, the amount (concentration) of the toxin contained in the medium M1 may be adjusted to decrease, and when the cholesterol content in the cell membrane is low, the amount of the toxin contained in the medium M1 ( The density may be adjusted in the increasing direction.
  • cells C are preferably cultured at a temperature of 0 ° C. or higher and 10 ° C. or lower, and preferably cultured at a temperature of 2 ° C. or higher and 5 ° C. or lower. That is, the temperature of the medium M1 is preferably 0 ° C. or higher and 10 ° C. or lower, and more preferably 2 ° C. or higher and 5 ° C. or lower.
  • the temperature of the culture medium M1 may be controlled by placing the culture container in which the well W is formed on ice. In the temperature range, the membrane perforation activity of toxin 1 is suppressed.
  • the toxin 1 binds to the cell membrane of the cell C, but the action of perforation is hardly exerted, and the degree of perforation of the cell membrane can be controlled more easily.
  • the culture time for culturing the cells C in the medium M1 (introducing agent) containing the toxin 1 may be appropriately determined according to the type of toxin and the cell type.
  • An example of the culture time is about 1 to 30 minutes.
  • the cell into which the substance is introduced is not particularly limited, and examples thereof include cells such as animal cells, plant cells, and insect cells, and microorganisms such as Escherichia coli, Bacillus subtilis, and yeast.
  • the cells may constitute cell aggregates such as cell clusters, spheroids, tissues, embryoid bodies, organs and the like.
  • the medium M1 After culturing the cells in the medium M1 (introducing agent), the medium M1 is replaced with the medium M2 not containing the toxin 1, the cells are cultured in the medium M2, and the cell membrane of the cell C is perforated.
  • the toxins 1 other than those bound to the cells C are removed from the reaction system in the well W.
  • the cells C are preferably cultured at 30 ° C. or higher and 40 ° C. or lower, more preferably cultured at 33 ° C. or higher and 38 ° C. or lower, and cultured at 35 ° C. or higher and 37 ° C. or lower. More preferably. That is, the temperature of the medium M2 is preferably 30 ° C. or higher and 40 ° C. or lower, more preferably 33 ° C. or higher and 38 ° C. or lower, and further preferably 35 ° C. or higher and 37 ° C. or lower.
  • the membrane perforation activity of toxin 1 is more exerted, the cell membrane of cell C is perforated, and a cell Cp having a pore formed in the cell membrane is obtained. Since the toxin 1 other than the toxin 1 bound to the cell C is removed from the medium M2, it is possible to prevent the toxin 1 from entering the cell further from the hole and perforating the organelle in the cytoplasm.
  • the culture time for culturing the cells C in the medium M2 may be appropriately determined according to the type of toxin and the cell type.
  • An example of the culture time is about 1 to 30 minutes.
  • the medium M2 the medium exemplified in the medium M1 may be used, but the TB (Transport Buffer) medium used in the examples can be exemplified as a particularly preferable medium.
  • the TB medium is prepared in consideration of the composition of cytoplasmic ions, and the influence of perforation of the cell membrane can be reduced.
  • the perforation is preferably performed by allowing the toxin 1 to act on the cell C under the condition of pH 6 to 10, more preferably 6.5 to 8 and more preferably 7.0 to 7 More preferably, it is carried out under the condition of 5 or less. That is, the pH of the medium M2 is preferably 6 or more and 10 or less, more preferably 6.5 or more and 8 or less, and even more preferably 7.0 or more and 7.5 or less.
  • the pH is a measured value in a temperature range of 30 ° C. or higher and 40 ° C. or lower. Within the above range, the cells can be cultured more favorably, and the membrane perforation activity of toxin 1 is also exhibited more gently.
  • the perforation is preferably performed by allowing toxin 1 to act on cell C under conditions of 30 ° C. or higher and 40 ° C. or lower and pH 6 or higher and 10 or lower, and under conditions of 33 ° C. or higher and 38 ° C. or lower and pH 6.5 or higher and 8 or lower. More preferably, it is carried out under the conditions of 35 ° C. to 37 ° C. and pH 7.0 to 7.5. That is, the medium M2 is preferably 30 ° C. or higher and 40 ° C. or lower and pH 6 or higher and 10 or lower, more preferably 33 ° C. or higher and 38 ° C. or lower, and pH 6.5 or higher and 8 or lower, more preferably 35 ° C. or higher and 37 ° C. or lower, and pH 7.0 or higher. 5 or less is more preferable.
  • the introducing step is a step of introducing a substance into the cell through the hole formed in the cell membrane in the perforating step.
  • FIG. 1D is a schematic diagram for explaining the introduction process.
  • the well W contains a medium M3 containing the substance 3 to be introduced into the cells Cp, and cells Cp in which pores have been formed in the cell membrane in the perforation step.
  • the substance 3 passes through the hole formed in the cell Cp and is introduced into the cell membrane of the cell Cp.
  • the medium M3 containing the substance 3 can be obtained, for example, by adding the substance 3 to the medium M2 in the drilling step.
  • the amount of the substance 3 contained in the medium M3 can be appropriately set according to the type of the substance 3.
  • the substance introduced into the cell is not particularly limited as long as it can be introduced into the cell by the method.
  • the molecular weight of the substance may be, for example, a molecular weight of 0.1 kDa to 20 kDa, 1 kDa to 15 kDa, or 5 kDa to 10 kDa.
  • the substance introduced into the cell may have a property of impermeable to the cell membrane.
  • the “substance having cell membrane impermeability” means a substance that does not dissolve in the lipid bilayer of the cell membrane and cannot permeate the lipid bilayer. According to the substance introduction method of the present embodiment, even a cell membrane impermeable substance can be introduced into cells through the pores with high efficiency.
  • the substance to be introduced into the cells is contained in the medium M3.
  • the substance introduction technique is limited to the above technique as long as the substance can be introduced through the pores formed in the cell membrane. It is not something.
  • Examples of the method of introducing a substance include a method of bringing a substance into contact with the cell Cp, a method of spraying a substance directly on the cell Cp, a method of dropping a substance directly on the cell Cp, and the like.
  • the substance introduced into the cell may be a compound or an organic compound.
  • the substance may contain a nucleic acid.
  • the nucleic acid include antisense nucleic acid, miRNA, siRNA, shRNA, ribozyme, aptamer and the like. These compounds can be active ingredients of nucleic acid drugs. Compounds containing these nucleic acids are normally impermeable to cell membranes, but according to the substance introduction method of this embodiment, they can be efficiently introduced into cells.
  • the re-encapsulation step is a step of bringing the solution containing calcium ions into contact with the cells in which the pores are formed and re-encapsulating the pores after the introduction step.
  • FIG. 1E is a schematic diagram for explaining the re-encapsulation process. As shown in FIG. 1 (e), the medium M4 contains calcium ions (Ca 2+ ).
  • re-encapsulation means that the opening of the hole formed in the cell membrane in the perforation step is completely or partially closed. Re-encapsulation is caused by removal of toxin 1 from the cell membrane by at least one of endocytosis and exocytosis, and is promoted by the presence of calcium ions.
  • the cell Cp cultured in the medium M4 containing Ca 2+ has the cell membrane resealed to become a cell C.
  • the substance 3 introduced into the cell in the introduction step is efficiently held in the cell C by re-encapsulation.
  • the concentration of the calcium ions brought into contact with the cells may be 0.1 mmol / L or more and 10 mmol / L or less, and may be 0.5 mmol / L or more and 5 mmol / L or less. That is, the concentration of calcium ions contained in the medium M4 may be 0.1 mmol / L or more and 10 mmol / L or less, and may be 0.5 mmol / L or more and 5 mmol / L or less.
  • the liquid containing calcium ions can be obtained, for example, by adding a calcium salt to the medium M3 in the introduction step.
  • a calcium salt to be added examples include CaCl 2 .
  • the re-encapsulation step it is preferable to re-encapsulate the pores without bringing a solution containing foreign cytoplasm into contact with the cells in which the pores are formed.
  • the cytoplasm contains a factor that promotes at least one of endocytosis and exocytosis.
  • re-encapsulation was performed by bringing a solution containing foreign cytoplasm into contact with the cells in which the pores were formed.
  • the cytoplasm component is released to the outside by perforation, it is considered that it was effective to replenish the released cytoplasm.
  • re-encapsulation since it is difficult for damage to cells, re-encapsulation is considered to be performed well without adding cytoplasm from the outside when re-encapsulating the cell membrane.
  • foreign cytoplasm means the cytoplasm of cells other than the substance introduction target cell that has been treated with an introduction agent and perforated.
  • the cytoplasm of the cell Cp in which pores are formed in the cell membrane does not correspond to the foreign cytoplasm.
  • the foreign cytoplasm is a cytoplasm obtained from cells other than the cells C and Cp accommodated in the well W.
  • the type of foreign cytoplasm may be a cytoplasm of a different type of cell from the cell into which the substance is introduced, a cytoplasm of the same type of cell, or a cytoplasm prepared from a tissue.
  • a liquid containing a foreign cytoplasm may be brought into contact with the cells in which the pores are formed.
  • the foreign cytoplasm is at least one of the medium M3 and the medium M4.
  • the cells may be cultured by adding them.
  • cells may be cultured in a medium containing an ATP regeneration system, or cells may be cultured in a medium containing an ATP regeneration system in at least one of the introduction step and the re-encapsulation step.
  • the cells may be cultured by adding an ATP regeneration system to at least one of the medium M3 and the medium M4.
  • the ATP regeneration system include a combination of ATP, creatine kinase, and creatine phosphate.
  • the drilling process and the introduction process are performed as independent processes, but the drilling and the substance introduction may occur almost simultaneously.
  • the substance 3 is added to the M3 medium after the perforation process.
  • the substance 3 may be added to the medium M2 of the perforation process.
  • the re-encapsulation process was implemented in the substance introduction method of this embodiment, the re-encapsulation process is not an essential process in the substance introduction method of this embodiment.
  • Step 1 indicates the above-mentioned “drilling step” and the above-mentioned “introduction step”.
  • Step 1a indicates the above-mentioned “perforation step” and the above-mentioned “introduction step” in the case where cholesterol-dependent cytolytic toxin is used as a specific example of the introduction agent.
  • Step 2 indicates a re-encapsulation step.
  • the substance introduction method of the present embodiment by using the above-described introduction agent, it is difficult to cause damage to cells, and a substance can be introduced into cells with high efficiency.
  • a substance can be introduced into cells with high efficiency.
  • re-encapsulation is satisfactorily performed without adding cytoplasm from the outside, and the substance is retained in the cell.
  • the screening method according to an embodiment of the present invention is a method using the above-described substance introduction method, wherein the substance to be introduced into the cell is a test substance, and the introduction agent is contacted with the cell to perforate a cell membrane.
  • a method comprising the step A of introducing a test substance into the cell.
  • the screening method of this embodiment is: A perforation step of perforating a cell membrane by contacting the introduction agent with a cell; An introducing step of introducing a test substance into the cells through the holes formed in the cell membrane in the perforating step; An evaluation step of comparing the cell into which the test substance is introduced and the cell into which the test substance is not introduced, and evaluating the test substance.
  • test substances include expression products of gene libraries, synthetic low molecular weight compound libraries, peptide libraries, nucleic acid libraries, antibodies, bacterial release substances, cells (microorganisms, plant cells, animal cells) extracts and cultures. Examples include supernatants, purified or partially purified polypeptides, marine organisms, plant or animal extracts, soils, random phage peptide display libraries, and the like.
  • transduction method can be illustrated as a suitable thing.
  • the perforating step and the introducing step are as described in the substance introducing method. Moreover, as a method for introducing a test substance, the method exemplified in the above-described substance introduction method can be exemplified. Further, the perforation process and the introduction process may be independent processes, and the perforation and the substance introduction may occur almost simultaneously. Moreover, you may implement the above-mentioned re-encapsulation process after an introduction process and before an evaluation process. “Step A” indicates the above-mentioned “perforation step” and the above-mentioned “introduction step” when the substance to be introduced into the cell is a test substance. “Process B” refers to an evaluation process described later.
  • the test substance introduced into the cell can exert its function inside the cell.
  • the evaluation step is a step of evaluating the test substance by comparing a cell into which the test substance is introduced and a cell into which the test substance is not introduced. What is necessary is just to set a comparison item suitably according to the objective of screening. For example, if the active ingredient of a therapeutic or preventive agent for disease A is screened, the degree of phenotype associated with disease A may be used as a comparison item.
  • the test substance can be an active ingredient of a therapeutic or preventive agent for disease A.
  • the cell comparison may be performed on a cell preparation such as a cell extract, a slice, or an amplification product of a nucleic acid obtained from the cell.
  • the substance introduction method of the present embodiment since the substance introduction method of the present embodiment is used, it is difficult to cause damage to cells, the test substance can be introduced into cells with high efficiency, and the original function of the cell is reflected. High-accuracy screening of test substances becomes possible.
  • Listeriolysin O (CEDARLANE, model number: CLPRO320)
  • Streptricin O (SLO): (manufactured by Bio Academia, model number: 01-531)
  • FITC-dextran 150 (TdB, model number: FD150)
  • Dextran Fluorescein, 40,000 MW
  • Anionic, Lysine Fixable (Invitrogen, model number: D1845) Dextran, Fluorescein, 10,000 MW
  • Anionic, Lysine Fixable (Fluoro-Emerald): (Invitrogen, model number: D1820) Dextran, Fluorescein, 70,000 MW
  • Anionic, Lysine Fixable (Invitrogen, model number: D1822)
  • TB transport buffer: 25 mM Hepes, 1.15 mM KOAC, 250 ⁇ M MgCl 2 , 2 mM EGTA, pH 7.2
  • 37 Incubation was performed at 0 ° C. for 10 minutes to form perforations in the cell membrane.
  • Dextran was introduced into cells of less than or equal to 70%, 53% or less at 70 kDa, and 42% or less at 150 kDa. Under the conditions of the concentration used in this example, dextran up to about 10 kDa can freely pass through the pores formed by LLO, and in the case of dextran having a higher molecular weight, it can easily pass depending on the concentration of LLO. Was found to change.
  • Drilling step HeLa cells were cultured for 5 minutes on ice in DMEM (-FCS) containing LLO (0.15 ⁇ g / mL) or SLO (0.125 ⁇ g / mL) to act on LLO or SLO. The cells were washed with PBS, and then incubated at 37 ° C. for 10 minutes with TB containing warm propidium iodide (PI). PI is a cell membrane-impermeable nucleic acid stain, and only cells with holes in the cell membrane are stained.
  • Re-encapsulation step 1 mM CaCl 2 was added and incubated at 37 ° C. for 5 minutes, and the cell membrane was closed again.
  • resealed cells that had been punctured with LLO remained clean and intact, with or without the addition of cytoplasm.
  • SLO protruding membrane
  • Example 3 Functional analysis of cells after introduction of molecules by LLO 1
  • a membrane-impermeable molecule was introduced into the cell using LLO without the addition of exogenous cytoplasm and the function of the molecule in the cell was assayed. It was a membrane impermeable analog of cAMP used for introduction. Since cAMP activates PKA, the phosphorylation of the substrate protein by PKA after introduction of cAMP analog was verified.
  • the 150 kDa band was detected slightly stronger when cAMP active analog was introduced and significantly weaker when cAMP inactive analog was introduced, as in the intact control experiment. This means that the membrane-impermeable cAMP analog introduced by the LLO treatment certainly functions in the cell.
  • Example 4 Functional analysis of cells after molecule introduction by LLO 2 Next, again, a membrane-impermeable molecule was introduced into the cell using LLO without the addition of exogenous cytoplasm, and the intracellular function of the molecule was assayed. It was a membrane impermeable analog of cAMP used for introduction. Since cAMP activates PKA, the phosphorylation of the substrate protein by PKA after introduction of cAMP analog was verified.
  • FIG. 9A A lysate was prepared from the cultured cells, and a protein band phosphorylated by PKA was detected by Western blotting using an anti-phospho PKA substrate antibody. The results are shown in FIG. 9A.
  • “band-a” to “band-i” indicate a plurality of bands that change in a concentration-dependent manner with respect to db-cAMP.
  • GAPDH is a loading control.
  • band-e was used as an index of phosphorylation of the substrate protein when cAMP membrane impermeable analog was added to resealed cells by LLO.
  • FIG. 9B is a graph obtained by quantifying the band-e luminance with respect to the GAPDH luminance. Also from FIG. 9B, it was confirmed that the band-e luminance with respect to the GAPDH luminance increased in a concentration-dependent manner with respect to db-cAMP.
  • the band-e was remarkably detected when the cAMP active analog, which is a membrane-impermeable activator, was introduced, as in the intact control experiment.
  • the band-e was detected slightly weaker when db-cAMP, which is a membrane permeability activator, was introduced, compared to the intact control experiment.
  • FIG. 10B is a graph obtained by quantifying the band-e luminance with respect to the ⁇ -tubulin luminance from the detection result of Western blotting in FIG. 10A.
  • FIG. 10B also confirmed that the band-e luminance relative to the ⁇ -tubulin luminance was higher when the membrane-impermeable cAMP analog was introduced than when the membrane-permeable activator db-cAMP was introduced. .
  • the band-e was remarkably detected as in the intact control experiment.
  • the band-e was detected slightly weaker than the intact control experiment.
  • FIG. 11B is a graph obtained by quantifying the band-e luminance with respect to the ⁇ -tubulin luminance from the detection result of Western blotting in FIG. 11A. Also from FIG. 11B, it was confirmed that the band-e luminance with respect to the ⁇ -tubulin luminance increases when the substance introduction method of this embodiment is used.
  • db-cAMP a membrane permeability activator
  • Akt is a serine / threonine kinase having a PH (Plekstrin Homology) domain at the N-terminus.
  • Akt is an important intracellular signaling factor that controls cell death (apoptosis). Akt is activated by phosphorylation of Thr308 and Ser473. Therefore, the phosphorylation of Akt after introduction of the Akt inhibitor was verified.
  • Intracellular introduction of an Akt inhibitor using LLO was performed by the following method.
  • the schematic diagram of each process is shown to FIG. 12A.
  • the upper arrow shows the outline of the operation in each step.
  • the lower square indicates the type and timing of the reagent added for each sample.
  • Akt inhibitor a peptide (Akt-in) composed of an amino acid sequence represented by 1 mM of SEQ ID NO: 1 (AVDTHPDRLWAWEKF), a TAT-labeled peptide (TAT) composed of an amino acid sequence represented by SEQ ID NO: 2 (YGRKKRRQRRRAVTHPDRLWAWEKF) of 50 ⁇ M. -Akt-in) or 31.2 ⁇ M triciribine.
  • phosphorylated Akt was significantly and strongly detected by EGT stimulation in cells cultured in the absence of an Akt inhibitor.
  • phosphorylated Akt was detected significantly weaker than cells cultured in the absence of an Akt inhibitor.
  • FIG. 12C is a graph in which the luminance of phosphorylated Akt (P-Akt) with respect to the luminance of total Akt (Total-Akt) is quantified based on the detection result of Western blotting in FIG. 12B.
  • FIG. 12C also confirms that in the cells cultured in the absence of the Akt inhibitor, the brightness of phosphorylated Akt (P-Akt) relative to the brightness of total Akt (Total-Akt) is significantly increased by EGT stimulation. It was.
  • the brightness of phosphorylated Akt (P-Akt) relative to the brightness of total Akt (Total-Akt) is higher than in the cells cultured in the absence of the Akt inhibitor. It was confirmed that it decreased significantly.
  • total-Akt phosphorylated Akt
  • Total-Akt phosphorylated Akt
  • Akt-in membrane-impermeable Akt inhibitor
  • the introduction agent, kit, and introduction method of the present embodiment damage to cells is difficult to occur, and a substance can be introduced into cells with high efficiency.
  • the screening method of the present embodiment it is difficult to cause damage to cells, and the test substance can be introduced into the cell with high efficiency, so that it is possible to screen the test substance with high accuracy reflecting the original function of the cell. It becomes.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Cet agent d'introduction comprend une cytolysine dépendant du cholestérol, pour laquelle le pH optimal pour l'activité de perforation de la membrane à 30-40 °C est au moins égal à 0, mais inférieur à 6, ledit agent d'introduction étant utilisé pour l'introduction d'une substance dans une cellule. Ce kit comprend l'agent d'introduction et est utilisé pour l'introduction d'une substance dans une cellule. Ce procédé d'introduction de substance comprend une étape 1 consistant à perforer une membrane cellulaire en amenant l'agent d'introduction en contact avec la cellule, puis à introduire une substance dans la cellule. Ce procédé de criblage d'une substance utilise le procédé d'introduction de substance, et la substance introduite dans la cellule est la substance devant être criblée.
PCT/JP2017/025749 2016-07-19 2017-07-14 Agent d'introduction, kit, procédé d'introduction de substance et procédé de criblage WO2018016440A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018528525A JP7093557B2 (ja) 2016-07-19 2017-07-14 導入剤、キット、物質導入方法、及びスクリーニング方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016-141219 2016-07-19
JP2016141219 2016-07-19

Publications (1)

Publication Number Publication Date
WO2018016440A1 true WO2018016440A1 (fr) 2018-01-25

Family

ID=60992529

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2017/025749 WO2018016440A1 (fr) 2016-07-19 2017-07-14 Agent d'introduction, kit, procédé d'introduction de substance et procédé de criblage

Country Status (2)

Country Link
JP (1) JP7093557B2 (fr)
WO (1) WO2018016440A1 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09500102A (ja) * 1993-04-28 1997-01-07 ウォーセスター ファウンデーション フォー エクスペリメンタル バイオロジー 細胞指向性溶解孔形成剤
JP2001515455A (ja) * 1995-06-07 2001-09-18 プレジデント・アンド・フェローズ・オブ・ハーバード・カレッジ 細胞内への巨大分子の輸送
US20080254046A1 (en) * 2005-04-08 2008-10-16 Christoph Von Eichel-Streiber Method for the Delivery of Exogenous Antigens into the Mhc Class I Presentation Pathway of Cells
JP2013213688A (ja) * 2012-03-30 2013-10-17 Kanagawa Academy Of Science And Technology 高脂血症又は糖尿病の検出方法及び疾患の治療剤のスクリーニング方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09500102A (ja) * 1993-04-28 1997-01-07 ウォーセスター ファウンデーション フォー エクスペリメンタル バイオロジー 細胞指向性溶解孔形成剤
JP2001515455A (ja) * 1995-06-07 2001-09-18 プレジデント・アンド・フェローズ・オブ・ハーバード・カレッジ 細胞内への巨大分子の輸送
US20080254046A1 (en) * 2005-04-08 2008-10-16 Christoph Von Eichel-Streiber Method for the Delivery of Exogenous Antigens into the Mhc Class I Presentation Pathway of Cells
JP2013213688A (ja) * 2012-03-30 2013-10-17 Kanagawa Academy Of Science And Technology 高脂血症又は糖尿病の検出方法及び疾患の治療剤のスクリーニング方法

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DARJI, AYUB ET AL.: "TAP-dependent major histocompatibility complex class I presentation of soluble proteins using listeriolysin", EUR. J. IMMUNOL., vol. 27, 1997, pages 1353 - 1359, XP008052731, DOI: doi:10.1002/eji.1830270609 *
GLOMSKI, IAN J. ET AL.: "The Listeria monocytogenes hemolysin has an acidic pH optimum to compartmentalize activity and prevent damage to infected host cells", J. CELL. BIOL., vol. 156, no. 6, 2002, pages 1029 - 1038, XP002474667, DOI: doi:10.1083/jcb.200201081 *
KIM, NA HYUNG ET AL.: "Design and Characterization of Novel Recombinant Listeriolysin 0-Protamine Fusion Proteins for Enhanced Gene Delivery", MOLECULAR PHARMACEUTICS, vol. 12, 18 December 2014 (2014-12-18), pages 342 - 350 *
MATHEW, E. ET AL.: "Cytosolic delivery of antisense oligonucleotides by listeriolysin 0-containing liposomes", GENE THERAPY, vol. 10, 2003, pages 1105 - 1115, XP055002893, DOI: doi:10.1038/sj.gt.3301966 *
TWETEN, RODNEY K.: "Cholesterol-Dependent Cytolysins, a Family of Versatile Pore-Forming Toxins", INFECTION AND IMMUNITY, vol. 73, no. 10, 2005, pages 6199 - 6209, XP002614082, DOI: doi:10.1128/IAI.73.10.6199-6209.2005 *

Also Published As

Publication number Publication date
JPWO2018016440A1 (ja) 2019-05-09
JP7093557B2 (ja) 2022-06-30

Similar Documents

Publication Publication Date Title
Wang et al. Antibacterial mechanism of plantaricin LPL-1, a novel class IIa bacteriocin against Listeria monocytogenes
Liang et al. Metal-organic framework coatings as cytoprotective exoskeletons for living cells
Gemili et al. Development of cellulose acetate based antimicrobial food packaging materials for controlled release of lysozyme
Romero et al. An accessory protein required for anchoring and assembly of amyloid fibres in B. subtilis biofilms
Saeloh et al. The novel antibiotic rhodomyrtone traps membrane proteins in vesicles with increased fluidity
Vadia et al. The pore-forming toxin listeriolysin O mediates a novel entry pathway of L. monocytogenes into human hepatocytes
Florey et al. Autophagy machinery mediates macroendocytic processing and entotic cell death by targeting single membranes
Hagen et al. The antifungal protein AFP from Aspergillus giganteus inhibits chitin synthesis in sensitive fungi
Lerena et al. Mycobacterium marinum induces a marked LC3 recruitment to its containing phagosome that depends on a functional ESX‐1 secretion system
Freire et al. Action of silver nanoparticles towards biological systems: cytotoxicity evaluation using hen's egg test and inhibition of Streptococcus mutans biofilm formation
Elchinger et al. Immobilization of proteases on chitosan for the development of films with anti-biofilm properties
Simonin et al. Sequence of occurring damages in yeast plasma membrane during dehydration and rehydration: mechanisms of cell death
Velásquez et al. Induction of eryptosis by low concentrations of E. coli alpha-hemolysin
Munafo et al. DNase I inhibits a late phase of reactive oxygen species production in neutrophils
CN107206015A (zh) 透细胞质膜的传递
Lee et al. Differential induction of autophagy in caspase-3/7 down-regulating and Bcl-2 overexpressing recombinant CHO cells subjected to sodium butyrate treatment
CN108464998A (zh) 一种具有高稳定性的薄荷精油乳状液
Van De Weerd et al. Inorganic phosphate limitation modulates capsular polysaccharide composition in mycobacteria
DE69830602T2 (de) Teilchen
JP2006507010A (ja) 万能微生物検出方法、及び該方法の利用を可能にする反応媒体
Chanturiya et al. The role of membrane lateral tension in calcium-induced membrane fusion
Buzgariu et al. Chapter Twenty‐Six Methods to Investigate Autophagy During Starvation and Regeneration in Hydra
WO2018016440A1 (fr) Agent d'introduction, kit, procédé d'introduction de substance et procédé de criblage
Zavodnik et al. Hypochlorous acid-induced membrane pore formation in red blood cells
US20230241026A1 (en) Novel drug-controlled systems and uses thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17830959

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2018528525

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17830959

Country of ref document: EP

Kind code of ref document: A1